This program is supported through an independent educational grant from Johnson & Johnson. It is intended exclusively for healthcare professionals.

In this online teaching session, renowned ophthalmology experts Kamran Riaz, MD, and Eric Donnenfeld, MD, share high-impact, evidence-based strategies to enhance patient outcomes with presbyopia-correcting intraocular lenses (IOLs).

Accreditation: MedAll designates this activity for 1 CME Credit™.

Dr. Riaz and Dr. Donnenfeld provide practical guidance on personalizing IOL selection based on both anatomical and lifestyle factors, delivering peri-operative support that aligns expectations, and applying current clinical trial data to inform shared decision-making.

Session Highlights

• Match IOL to patient goals: Use clinical and lifestyle indicators to select the optimal presbyopia-correcting lens.
• Set expectations early: Apply structured peri-operative communication strategies to reduce dissatisfaction and improve adaptation.
• Counsel with confidence: Translate the latest trial data into accessible, personalized patient discussions.

Who Should Watch

• Ophthalmologists
• Optometrists
• Surgical coordinators
• Ophthalmic technicians
• Vision care professionals
• Other cataract surgery care team members

Presented by

Kamran M. Riaz, MD – Clinical Professor of Ophthalmology, Vice-Chair for Clinical Research, and Director of the Stephenson Refractive Surgery Center at the Dean McGee Eye Institute, University of Oklahoma. Dr. Riaz is a cornea and external disease specialist with expertise in presbyopia-correcting IOLs, premium cataract surgery, and laser vision correction. He has authored over 90 publications, trains residents and fellows in anterior segment surgery, and leads efforts to improve surgical outcomes and patient counseling.

Eric D. Donnenfeld, MD, FACS – Founding Partner, Ophthalmic Consultants of Long Island & Connecticut; Clinical Professor, NYU Grossman School of Medicine; Trustee, Geisel School of Medicine at Dartmouth. Dr. Donnenfeld is a global leader in cornea, cataract, and refractive surgery, a principal investigator in key FDA laser vision trials, and author of over 500 publications. He mentors fellows, has led multiple professional societies, and was named one of America’s Best Eye Doctors by Newsweek in 2021 and 2022.

With Advocacy from Prevent Blindness

Brenda Nickum had presbyopia-correcting intra-ocular lenses (IOLs) when she had cataract surgery in April 2011. Her surgeon created a “blended vision” (monovision) profile—one eye optimized for distance, the other for near work. Several months later, posterior-capsule haze developed and she underwent laser capsulotomies on both eyes (November 2011).

Disclosures

Kamran M. Riaz, MD has served as a consultant for AbbVie/ImmunoGen, Ambrx, Inc., Bausch and Lomb, Exelixis, Inc., and Neumora Therapeutics; has received research support from Nova Eye; receives royalties from Elsevier Publishing, Springer Publishing, and Wolters Kluwer Publishing; has received speaking fees from AbbVie, AudioDigest, Bausch and Lomb, Carl Zeiss Meditec, Inc., CorneaGen, and Medscape; and has received travel support from Aurion Therapeutics.

Eric Donnenfeld has stock ownership in ELT Sight, Mati Pharmaceuticals, Rayner and TenPoint Pharma. He has been a consultant for Abbvie, Aldeyra, Allegro, Alcon, and Aurio.

Brenda Niccum has no conflict of interest.

MedAll staff, as well as planners and reviewers, have no relevant financial relationships with ineligible companies to disclose.

CME Information:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the European Board for Accreditation of Continuing Education for Health Professionals (EBAC)

MedAll is an EBAC accredited provider since 2025. The European Board for Accreditation of Continuing Education for Health Professionals (EBAC) accredits Continuing Education (CE) programmes for the international medical community.

This program is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) for 1:00 hours of effective education time.

In compliance with EBAC guidelines, all speakers/ chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations. The Organizing Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CE activities.

EBAC® holds an agreement on mutual recognition of substantive equivalency with the US Accreditation Council for CME (ACCME) and the Royal College of Physicians and Surgeons of Canada, respectively.

Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) and the American Medical Association, physicians may convert EBAC® External CME credits to AMA PRA Category 1 Credits. Information on the process to convert EBAC® credit to AMA credit can be found on the AMA website. Other healthcare professionals may obtain from the AMA a certificate of participation in an activity eligible for conversion of credit to AMA PRA Category 1 Credit.

The Accreditation Council for Continuing Medical Education (ACCME) and the Royal College of Physicians and Surgeons of Canada hold an agreement on substantial equivalency of accreditation systems with EBAC.

EBAC® is a member of the International Academy for CPD Accreditation (IACPDA) and a partner member of the International Association of Medical Regulatory Authorities (IAMRA).

How to earn your CME credit:

In order to obtain your CME credit and acquire your certificate, please join the webinar and complete the assessment at the end. You will receive a link to your certificate automatically after completing the assessment.

Participation Costs

There is no cost to participate in this program.